Effects of nateglinide on DPP-IV activity and incretin hormone degradation in type 2 diabetic patients.

A.M. McKillop, N.A. Duffy, J.R. Lindsay, Brian Green, F.P.M. O'Harte, P.M. Bell, P.R. Flatt

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)367
JournalIrish journal of medical science
Issue number9
Publication statusPublished - 2007

Cite this